$18.83
-1.08-5.42%
al cierre: -
$19.20
0.371.96%
After hour: Apr 4, 8:26 AM EDT
iShares Genomics Immunology and Healthcare ETF (ARCA: IDNA)
Ticker | Name | Share % | |
---|---|---|---|
SM | Roche Holding A.G. | 5.49% | |
GILD | Gilead Sciences Inc | 4.62% | |
SRPT | Sarepta Therapeutics Inc | 4.53% | |
RVMD | Revolution Medicines Inc Ser C Pc Pp | 4.44% | |
INCY | Incyte Corp. | 4.30% | |
REGN | Regeneron Pharmaceuticals, Inc. | 4.23% | |
EXEL | Exelixis Inc | 5.05% | |
TK | Takeda Pharmaceutical Co Ltd | 4.95% | |
PA | Sanofi SA | 5.54% | |
HK | Beigene, Ltd. | 6.57% | |
SWTX | Springworks Therapeutics Inc | 4.73% | |
LN | GSK plc | 5.40% | |
CO | Genmab A.S. | 4.33% | |
MRK | Merck & Co. Inc. | 4.26% |
Quote.FAQ.Answers.ETFs.etf-performance
Quote.FAQ.Answers.ETFs.expense-ratio
Quote.FAQ.Answers.ETFs.aum
IDNA sigue un estilo de inversión Mid Cap Growth.
Las principales posiciones de IDNA incluyen: SM (5.49%), GILD (4.62%), SRPT (4.53%), RVMD (4.44%), INCY (4.3%). Estas representan las mayores posiciones en la cartera del ETF.
Los datos del volumen medio diario para IDNA no están disponibles actualmente.